Pharmaceuticals
Global Neuropathic Pain Market to 2032
Overview
The Global Neuropathic Pain Market is expected to reach a market size of 12,961,195.00 (USD Million) by 2032. During the forecast period of 2025–2032, the market is projected to grow at a CAGR of 9.17%.
Revenue, 2024 (USD Million)
6,312,105.00
Forecast, 2032 (USD Million)
12,961,195.00
CAGR, 2024 - 2032
9.17%
Report Coverage
Global
Global Neuropathic Pain Market 2018-2032 USD Million
Global Neuropathic Pain Market, Overview (2024-2032)
Market Growth and Projections:
- Market Size (2024): 6,312,105.00 USD Million
- Projected Market Size (2032): 12,961,195.00 USD Million
- CAGR (2024-2032): 9.17%
Key Findings of Global Neuropathic Pain Market
- The Global Neuropathic Pain Market is likely to grow at a CAGR of 9.17% during the forecast period of 2024 to 2032.
- Global Neuropathic Pain Marketsize was valued at 6,312,105.00 USD Million in 2024.
- In 2024, Prescription-Based Devices segment dominated the market with the largest market share.
- Peripheral Neuropathy in the product segment is expected to witness the fastest growth during the forecast period.
Global Neuropathic Pain Market Scope
Global Neuropathic Pain Market Segmentation & Scope
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Global Neuropathic Pain Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 6,312,105.00 USD Million |
| Market Value in 2032 | 12,961,195.00 USD Million |
| CAGR (2024-2032) | 9.17% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Modality,Mode of Purchase,Pain Type,Indication,Technology,Type,Product Type,Procedure,End User,Distribution Channel |
| Largest Segment | Prescription-Based Devices |
| Fastest Growing Segment | Peripheral Neuropathy |
| Major Players | Medtronic, Omron Healthcare, Inc., NEVRO CORP., Integer Holdings Corporation, Boston Scientific Corporation or its affiliates, Abbott, Others |
Market Segmentation:
-
Product Segment:
- Largest Segment (2024): Prescription-Based Devices
- Fastest Growing Segment (2024-2032): Peripheral Neuropathy
Regional Insights:
-
Leading Market (2024-2032): Global
- Key Country: U.S., leading in terms of revenue and market share by 2032.
Global Neuropathic Pain Market Company Share Analysis
| Name | Market Share | OwnnerShip | HQ | Website |
|---|---|---|---|---|
| Medtronic | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Omron Healthcare | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Inc. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| NEVRO CORP. | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Integer Holdings Corporation | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Boston Scientific Corporation or its affiliates | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Abbott | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
| Others | 1,944.00 | public/listed | Massachusetts | www.astrazeneca.com |
Global Neuropathic Pain Market Geographical Sales Distribution, 2018-2032 USD Million
Global Neuropathic Pain Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
Frequently Asked Questions
The Global Neuropathic Pain Market is segmented based on Segmentation Modality,Mode of Purchase,Pain Type,Indication,Technology,Type,Product Type,Procedure,End User,Distribution Channel.
Global Neuropathic Pain Market was valued at USD 6,312,105.00(Revenue in USD Million) in 2020.
Global Neuropathic Pain Market is projected to grow at a CAGR of 9.17% during the forecast period of 2024 to 2032.
The estimated market value of the Global Neuropathic Pain Market for final year is USD 12,961,195.00 (USD Million).
Global Neuropathic Pain Market Scope
Global Neuropathic Pain Market Segmentation & Scope
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Coccydynia
- Trigeminal Neuralgia
- Foot Pain
- Others
- Entrapment Neuropathy
- Post Traumatic Neuropathy
- Post Herpetic Neuralgia (PHN)
- Phantom Limb Pain
- Peripheral Neuropathy
Indication
- Others
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Spinal Stenosis
Technology
- Respiratory Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation
Type
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- External Peripheral Nerve Stimulation
- Spinal Cord Stimulation (SCS) Devices
Product Type
- Non-Rechargeable
- Rechargeable
Procedure
- Invasive
- Non-Invasive
End User
- Others
- Ambulatory Surgical Centers
- Home Healthcare
- Hospitals
- Clinics
Distribution Channel
- Others
- Third Party Distribution
- Direct Tenders
Global Neuropathic Pain Market Company Profiling
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | www.molnlycke.com |
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.